Thursday 30 June 2011
Thermo Fisher Scientific Collaboration with U.K. Health Protection Agency Yields Significant Development in Understanding Toxicity of the New E. coli Strain
WALTHAM, MASS. (June 29, 2011) Thermo Fisher Scientific Inc. the world leader in serving science, today announced that its collaboration with the Health Protection Agency (HPA) in the U.K. has led to a significant development in mapping the proteome of the organism responsible for the recent E. coli outbreak in Europe. Using Thermo Scientific LTQ Orbitrap mass spectrometry technology, HPA researchers have identified the protein toxins expressed by the deadly strain, which has resulted in 37 deaths and made nearly 3,400 people ill.
Tuesday 28 June 2011
Thermo Fisher Scientific Announces Breakthrough Workflow for Metabolomics Research
CAIRNS, Australia (June 27, 2011) - Thermo Fisher Scientific Inc., the world leader in serving science, today announced a breakthrough workflow to overcome key analytical and informatics challenges in metabolomics. The workflow integrates new application software -- Thermo Scientific SIEVE 2.0 differential expression analysis and Mass Frontier 7.0 structural elucidation software -- with powerful new Thermo Scientific high resolution accurate mass (HRAM) instruments: the Q Exactive high performance benchtop quadrupole-Orbitrap LC-MS/MS and the Orbitrap Elite hybrid mass spectrometer. The revolutionary new products accelerate even the most complex metabolomics studies. The complete solution can be seen at Thermo Scientific booth #9 during the 7th International Conference of the Metabolomics Society, which runs from June 27-30 in Cairns, Australia.
Friday 24 June 2011
Wyatt Technology MALS Fulfils Latest European Pharmacopoeia Standard for HES Characterization
(SANTA BARBARA, CALIFORNIA – June 24 2011) - Wyatt Technology Corporation, the world leader in instrumentation for absolute macromolecular characterization, announces that its Multi-Angle Light Scattering (MALS) instruments represent the latest European Pharmacopoeia (EP) requirements for hydroxyethyl starch (HES) characterization.
The European Pharmacopoeia is a single reference work developed by the European Directorate for the Quality of Medicines (EDQM). The official standards published within it provide a legal and scientific basis for quality control for all producers of medicines and/or substances for pharmaceutical use. A new publication within the EP specifically indicates that MALS instrumentation is the standard for characterizing HES.
The European Pharmacopoeia is a single reference work developed by the European Directorate for the Quality of Medicines (EDQM). The official standards published within it provide a legal and scientific basis for quality control for all producers of medicines and/or substances for pharmaceutical use. A new publication within the EP specifically indicates that MALS instrumentation is the standard for characterizing HES.
Thursday 23 June 2011
Thermo Fisher Scientific Announces ICP-MS Solution to Address Serious Concerns Regarding Chromium VI in Drinking Water
CAMBRIDGE, UK (June 22, 2011) - Thermo Fisher Scientific Inc., the world leader in serving science, today announced a highly sensitive ICP-MS solution for chromium measurement in drinking water, including the potentially carcinogenic hexavalent chromium (chromium VI). The Thermo Scientific XSERIES 2 ICP-MS is able to detect levels of chromium VI at less than 0.01 parts per billion (ppb), which is significantly lower than the current U.S. Environmental Protection Agency (EPA) guidelines of 0.5 ppb. Implementation of the system will provide laboratories with fast and accurate measurement of the element to ensure confident compliance with the EPA standards.
The Environmental Working Group (EWG), a nonprofit research organization, recently found chromium VI in the drinking water of 31 out of 35 U.S. cities tested, with the highest levels in samples from Norman in Oklahoma, Honolulu in Hawaii and Riverside, California. As a result of these findings, the EPA has advised U.S. water utilities to test more carefully for the presence of chromium in water sources. However, the methods on which many laboratories rely are not capable of meeting the desired 0.5 ppb level. ICP-MS methods in contrast offer unmatched sensitivity, from parts per billion into parts per trillion levels, for simultaneous analysis of numerous regulated contaminants in the EPA National Primary Drinking Water Regulations.
The Environmental Working Group (EWG), a nonprofit research organization, recently found chromium VI in the drinking water of 31 out of 35 U.S. cities tested, with the highest levels in samples from Norman in Oklahoma, Honolulu in Hawaii and Riverside, California. As a result of these findings, the EPA has advised U.S. water utilities to test more carefully for the presence of chromium in water sources. However, the methods on which many laboratories rely are not capable of meeting the desired 0.5 ppb level. ICP-MS methods in contrast offer unmatched sensitivity, from parts per billion into parts per trillion levels, for simultaneous analysis of numerous regulated contaminants in the EPA National Primary Drinking Water Regulations.
Wednesday 22 June 2011
Novozymes Biopharma to present on creating market opportunities through drug half-life extension at 2011 BIO Business Forum
Panel session and presentation will explore half-life extension technologies designed to overcome challenges associated with the therapeutic use of peptides and proteins.
NOTTINGHAM, UK - June 22, 2011 - Novozymes Biopharma, part of Novozymes A/S, the world leader in bioinnovation, today announced that it will be hosting a panel session within the manufacturing of biologics and drugs session track at the BIO Business Forum, during the 2011 BIO International Convention in Washington D.C, June 27-30. Svend Licht, senior director, Novozymes Biopharma will be moderating the session entitled 'Patient Compliance and market opportunities - the need for half-life extension' on Tuesday 28th June at 8.30am in room 156 AB, along with guest speakers from the world's leading drug development companies, including Pfizer, Sanofi, Teva Pharmaceuticals and Roche. The panel has been identified as leaders in their respective fields who use differing means of improving pharmacokinetics of biological drugs to offer enhanced benefits in the clinic.
NOTTINGHAM, UK - June 22, 2011 - Novozymes Biopharma, part of Novozymes A/S, the world leader in bioinnovation, today announced that it will be hosting a panel session within the manufacturing of biologics and drugs session track at the BIO Business Forum, during the 2011 BIO International Convention in Washington D.C, June 27-30. Svend Licht, senior director, Novozymes Biopharma will be moderating the session entitled 'Patient Compliance and market opportunities - the need for half-life extension' on Tuesday 28th June at 8.30am in room 156 AB, along with guest speakers from the world's leading drug development companies, including Pfizer, Sanofi, Teva Pharmaceuticals and Roche. The panel has been identified as leaders in their respective fields who use differing means of improving pharmacokinetics of biological drugs to offer enhanced benefits in the clinic.
Thermo Fisher Scientific GC/MS and LC/MS Instrumentation Selected by the Food and Environment Research Agency (Fera) to Ensure Food Safety
SAN JOSE, California (June 21, 2011) – Thermo Fisher Scientific Inc., the world leader in serving science, today announced that the Food and Environment Research Agency (Fera), an executive agency of the UK Government’s Department for Environment, Food and Rural Affairs (Defra), has selected Thermo Scientific GC-MS and LC-MS systems for accurate, rapid and cost-efficient analysis of food products.
Fera currently manages more than 600 research projects, analyzing more than 50,000 plant and food samples a year. It is the National Reference Laboratory for chemicals in food such as mycotoxins, polyaromatic hydrocarbons (PAHs), chemicals from food contact materials, dioxins and polychlorinated biphenyls (PCBs) in food and feed and some pesticides and veterinary drugs. The agency is now using the Thermo Scientific TSQ Quantum GC-MS/MS and Exactive high-performance benchtop LC-MS systems to analyze food, feed, water and air samples for potential contamination. As a result, Fera has benefited from substantial time savings as well as accurate and consistently reliable results. To learn more about the products used by Fera please visit: http://www.thermoscientific.com/foodsafety.
Fera currently manages more than 600 research projects, analyzing more than 50,000 plant and food samples a year. It is the National Reference Laboratory for chemicals in food such as mycotoxins, polyaromatic hydrocarbons (PAHs), chemicals from food contact materials, dioxins and polychlorinated biphenyls (PCBs) in food and feed and some pesticides and veterinary drugs. The agency is now using the Thermo Scientific TSQ Quantum GC-MS/MS and Exactive high-performance benchtop LC-MS systems to analyze food, feed, water and air samples for potential contamination. As a result, Fera has benefited from substantial time savings as well as accurate and consistently reliable results. To learn more about the products used by Fera please visit: http://www.thermoscientific.com/foodsafety.
Thermo Fisher Scientific Presents Innovative Instrumentation at GIFA 2011 for Metal Measurement and Analysis
ECUBLENS, Switzerland (June 21, 2011) – Thermo Fisher Scientific Inc., the world leader in serving science, will showcase its range of detection and measurement instruments at GIFA 2011, the 12th International Foundry Trade Fair, from June 28 – July 2, in Düsseldorf, Germany. It will highlight automation and process solutions that aid workflow production and provide fast and precise results, including the Thermo Scientific automated OES and XRF metals analyzers, the Thermo Scientific RM 200 EM strip thickness gauge and the Thermo Scientific RadEye range, which provides radiation measurement and protection for industrial applications. For more information, visit the Thermo Scientific booth G41, Hall 12 during GIFA 2011.
During GIFA, Thermo Fisher will showcase the Thermo Scientific ARL SMS-2500 automation system, which provides an integrated, workflow-orientated solution specifically designed for high-speed production control laboratories in the metals industries. By enabling direct access to the milling machine for the preparation of samples, processing time is reduced and expensive electromechanical sample transfer systems are eliminated.
Customers can select the best milling solution, such as the Thermo Scientific Haas Mini Mill combined with the Thermo Scientific ARL PrepControl, depending on preferences, needs and budgets. The Haas Mini Mill, teamed with the ARL PrepControl, addresses the requirements of modern process control laboratories for rapid and reliable metals sample preparation.
During GIFA, Thermo Fisher will showcase the Thermo Scientific ARL SMS-2500 automation system, which provides an integrated, workflow-orientated solution specifically designed for high-speed production control laboratories in the metals industries. By enabling direct access to the milling machine for the preparation of samples, processing time is reduced and expensive electromechanical sample transfer systems are eliminated.
Customers can select the best milling solution, such as the Thermo Scientific Haas Mini Mill combined with the Thermo Scientific ARL PrepControl, depending on preferences, needs and budgets. The Haas Mini Mill, teamed with the ARL PrepControl, addresses the requirements of modern process control laboratories for rapid and reliable metals sample preparation.
Tuesday 21 June 2011
ERT Appoints Robert Kleiman MD to Chief Medical Officer
PHILADELPHIA, PA – 21 June, 2011 ERT, a global technology-driven provider of clinical services and customizable medical devices to biopharmaceutical and healthcare organizations, announced today that Robert Kleiman, M.D. has been appointed to the role of Chief Medical Officer in addition to his current role as Vice President of Global Cardiology.
Dr. Kleiman graduated from Brown University Medical School with residency in Internal Medicine and completed Fellowships in Cardiology and Cardiac Electrophysiology at the University of Pennsylvania. Prior to joining ERT as a full time employee in April 2004, Dr. Kleiman had worked for ERT as an independent contractor through his cardiology and cardiac electrophysiology practice since 1994. Dr. Kleiman has managed ERT’s cardiology group, which has more than tripled in size since 2004, while maintaining ERT’s standards for high quality and consistency.
Dr. Kleiman graduated from Brown University Medical School with residency in Internal Medicine and completed Fellowships in Cardiology and Cardiac Electrophysiology at the University of Pennsylvania. Prior to joining ERT as a full time employee in April 2004, Dr. Kleiman had worked for ERT as an independent contractor through his cardiology and cardiac electrophysiology practice since 1994. Dr. Kleiman has managed ERT’s cardiology group, which has more than tripled in size since 2004, while maintaining ERT’s standards for high quality and consistency.
Thermo Fisher Scientific Introduces Expanded Chromatography Portfolio at HPLC 2011
BUDAPEST (June 20, 2011) - Thermo Fisher Scientific Inc., the world leader in serving science, today announced it will show its expanded portfolio of market-leading chromatography solutions within the Thermo Scientific and Dionex booths at HPLC 2011, a first since Thermo Fisher acquired Dionex.
Among the range of instruments, software and consumables on display will be the newly launched Thermo Scientific Accucore HPLC column range. These new products, alongside launches of mass spectrometry and liquid chromatography instruments used in advanced proteomic research, can be seen within the Thermo Scientific (M11-12) and Dionex (M 16-17) booths during the 36th International Symposium on High-Performance Liquid Phase Separations and Related Techniques (HPLC 2011), June 19-23, Budapest.
“By combining the rich heritage of the existing Thermo Scientific and Dionex chromatography offerings with our new offerings being launched at HPLC, Thermo Fisher is giving customers an even more comprehensive portfolio of chromatography instruments, consumables, software, services and applications expertise,” said Greg Herrema, president, analytical instruments at Thermo Fisher Scientific. “The new capabilities presented at HPLC are creating greater possibilities for scientists worldwide, making analyses more comprehensive and ensuring optimal speed, sensitivity and versatility."
Among the range of instruments, software and consumables on display will be the newly launched Thermo Scientific Accucore HPLC column range. These new products, alongside launches of mass spectrometry and liquid chromatography instruments used in advanced proteomic research, can be seen within the Thermo Scientific (M11-12) and Dionex (M 16-17) booths during the 36th International Symposium on High-Performance Liquid Phase Separations and Related Techniques (HPLC 2011), June 19-23, Budapest.
“By combining the rich heritage of the existing Thermo Scientific and Dionex chromatography offerings with our new offerings being launched at HPLC, Thermo Fisher is giving customers an even more comprehensive portfolio of chromatography instruments, consumables, software, services and applications expertise,” said Greg Herrema, president, analytical instruments at Thermo Fisher Scientific. “The new capabilities presented at HPLC are creating greater possibilities for scientists worldwide, making analyses more comprehensive and ensuring optimal speed, sensitivity and versatility."
Monday 20 June 2011
Pfizer Selects Exco InTouch’s Novel eDiary Technologies to Initiate First Ever Patient-Centered Clinical Trial
(20 June, 2011) Exco InTouch, the leading provider of patient communication solutions for the pharmaceutical and healthcare sectors, has announced that its novel eDiary technologies have been selected by Pfizer, the world’s leading pharmaceutical company, as part of the first ever Participatory Patient-Centered (PPC) clinical trial. The pilot study will utilize Exco InTouch’s leading eDiary technologies to enable patients to participate regardless of location, age or proximity to site. Focusing on new Research on Electronic Monitoring of OAB Treatment Experience (REMOTE) Phase 4 for the treatment of overactive bladder, the study will mimic a previously completed trial in order to replicate the results and validate this novel approach.
In order to support the success of this patient-centered, field-based clinical research, Pfizer required a mobile technology platform offering an ease-of-use interface that provided accessibility particularly for older patients. With an estimated five billion cellphone users worldwide, cell phones make an ideal and accessible platform for patient engagement in clinical trials. As part of the revolutionary new approach piloted by the REMOTE study, patients will be empowered to participate remotely in the screening process through trials via the internet, participate in trials that due to location may not have previously been possible, actively manage their own trial and report results directly to a trial. As a result, researchers expect to save time and obtain more reliable, higher quality data through increased patient compliance and engagement, lower withdrawal rates and real-time data collection. The new approach will also eliminate the significant costs associated with the management and co-ordination of running multiple clinical sites.
In order to support the success of this patient-centered, field-based clinical research, Pfizer required a mobile technology platform offering an ease-of-use interface that provided accessibility particularly for older patients. With an estimated five billion cellphone users worldwide, cell phones make an ideal and accessible platform for patient engagement in clinical trials. As part of the revolutionary new approach piloted by the REMOTE study, patients will be empowered to participate remotely in the screening process through trials via the internet, participate in trials that due to location may not have previously been possible, actively manage their own trial and report results directly to a trial. As a result, researchers expect to save time and obtain more reliable, higher quality data through increased patient compliance and engagement, lower withdrawal rates and real-time data collection. The new approach will also eliminate the significant costs associated with the management and co-ordination of running multiple clinical sites.
Thursday 16 June 2011
Greenphire Partners with Mytrus to Provide Web-Based Solutions that Revolutionize Patient Recruitment and Retention, Enhancing Study Efficiency
Philadelphia, PA, (16 June, 2011). Greenphire, the industry leading provider of clinical payment and communication technology solutions, has announced the partnership with Mytrus to deliver novel and efficient web-based solutions for clinical trial patients. In an industry characterized by timeless corporate giants like Johnson & Johnson, Pfizer, and Merck, two young technology companies are partnering to transform the clinical research environment. Recognizing longstanding deficiencies in the traditional clinical trials process, Greenphire LLC, based in Philadelphia and San Francisco startup Mytrus Inc. have developed web-based solutions to streamline the arduous and expensive tasks of recruiting, retaining, and efficiently administering clinical trials. Greenphire’s ClinCard System, a web-based patient payment, management and communication platform, compliments the functionality offered by Mytrus and its innovative methods for allowing patients to participate in clinical research studies directly from their own homes.
By revolutionizing the clinical research process with these new technologies, Greenphire and Mytrus hope to empower patients to play a larger and more critical role in pharmaceutical development. In contrast to the traditional environment in which patients have often needed to repeatedly travel long distances to be evaluated by participating medical centers, Mytrus allows patients to use innovative web technology to provide their own study data over the internet and then be immediately compensated directly to a Greenphire ClinCard debit card the patient carries around in their wallet.
By revolutionizing the clinical research process with these new technologies, Greenphire and Mytrus hope to empower patients to play a larger and more critical role in pharmaceutical development. In contrast to the traditional environment in which patients have often needed to repeatedly travel long distances to be evaluated by participating medical centers, Mytrus allows patients to use innovative web technology to provide their own study data over the internet and then be immediately compensated directly to a Greenphire ClinCard debit card the patient carries around in their wallet.
Wednesday 15 June 2011
Thermo Fisher Scientific Introduces TraceFinder 1.1 Routine Quantitative LC-MS Software at ASMS 2011
Compatible with all Thermo Scientific quantitative mass spectrometry platforms and the Transcend system, software offers one, easy-to-use solution for laboratories performing routine LC-MS
DENVER (June 10, 2011) - Thermo Fisher Scientific Inc., the world leader in serving science, today introduced Thermo Scientific TraceFinder 1.1, its latest software for clinical research, forensic toxicology, food safety and environmental testing laboratories performing routine, high-throughput quantitation by LC-MS. The software retains all of the capabilities of its predecessor and has been expanded to include complete integration with the Thermo Scientific Transcend system. It is also compatible with all Thermo Scientific quantitative mass spectrometry platforms, including the Thermo Scientific Exactive and LTQ family of systems. The software can be seen at Thermo Scientific Booth 110 or the Thermo Scientific hospitality suite at the Hyatt Regency in Centennial Ballroom D during the 59th Annual ASMS Conference on Mass Spectrometry and Allied Topics, from June 5–9 in Denver.
“Our customers asked for easy-to-use software for routine LC-MS quantitation that integrates seamlessly with their front-end system of choice - the Transcend System - and all of the Thermo Scientific quantitative LC-MS systems, including the LTQ series and the Exactive,” said Ian Jardine, vice president of global R&D, Thermo Fisher Scientific. “We enhanced TraceFinder 1.1 specifically to meet these needs, and now customers have one software solution for method development, data acquisition, data processing and report generation that they can use with our Thermo Scientific TSQ Series triple stage quadrupole system, the Exactive, Orbitrap or one of our ion trap systems. This will enable them to significantly improve laboratory productivity.”
Friday 10 June 2011
Thermo Fisher Scientific Introduces New System for Effortless Ultra High Pressure LC-MS Proteomics Analysis at ASMS 2011
DENVER (June 09, 2011) - Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of a new split-free, nano-flow UHPLC system. The Thermo Scientific EASY-nLC 1000 is the newest addition to the EASY-nLC family of nano-LC products. The EASY-nLC 1000 is unique in its ability to facilitate dedicated separation of biomolecules, such as proteins and peptides, at ultra-high pressures. The instrument is extremely easy to use and can seamlessly integrate with the complete range of Thermo Scientific mass spectrometry (MS) systems for instant, trouble-free operation. The new instrument will be displayed for the first time in the Thermo Scientific hospitality suite at the Hyatt Regency in Centennial Ballroom D during the 59th Annual ASMS Conference on Mass Spectrometry and Allied Topics, from June 5–9 in Denver.
The Thermo Scientific EASY-nLC 1000 uses shorter gradients on 50 µm UHPLC columns with 1.9 µm beads, delivering superior separation capability with razor-sharp peaks. As a result of its advanced design, the EASY-nLC 1000 facilitates as much as 30 percent more peptide and protein identifications by providing higher pressure ratings, along with independent and simultaneous variations of bead size and column length. Increasing the number of identifications is a significant achievement for proteomic research and discovery purposes. The EASY-nLC 1000 operates on the Thermo Scientific Xcalibur software platform, easily connecting and interfacing with the full suite of Thermo Scientific LC-MS systems.
The Thermo Scientific EASY-nLC 1000 uses shorter gradients on 50 µm UHPLC columns with 1.9 µm beads, delivering superior separation capability with razor-sharp peaks. As a result of its advanced design, the EASY-nLC 1000 facilitates as much as 30 percent more peptide and protein identifications by providing higher pressure ratings, along with independent and simultaneous variations of bead size and column length. Increasing the number of identifications is a significant achievement for proteomic research and discovery purposes. The EASY-nLC 1000 operates on the Thermo Scientific Xcalibur software platform, easily connecting and interfacing with the full suite of Thermo Scientific LC-MS systems.
Wednesday 8 June 2011
Thermo Fisher Scientific Launches New GC-MS/MS Instrument for Superior Selectivity and Sensitivity at ASMS 2011
DENVER (June, 07, 2011) - Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of its new triple quadrupole gas chromatography-mass spectrometry (GC-MS/MS) system designed to offer best-in-class selectivity, analytical performance and productivity. The Thermo Scientific TSQ Quantum XLS Ultra delivers the increased matrix selectivity needed for challenging applications that require lower levels of quantitation in extremely complex matrix extracts. With its exceptional sensitivity, easy detection and reliable peak integration, the system provides superior performance for the most difficult of matrix challenges. The TSQ Quantum XLS Ultra can be seen at the Thermo Scientific hospitality suite at the Hyatt Regency in Centennial Ballroom D during the 59th Annual ASMS Conference on Mass Spectrometry and Allied Topics, from June 5–9 in Denver.
The TSQ Quantum XLS Ultra is designed to offer best-in-class selectivity and precision for a wide range of GC-MS applications, including environmental, food safety, forensics, metabolomics and pharmaceutical. The new DuraBrite IRIS technology offers greater sensitivity, extended maintenance cycles and high routine matrix robustness so scientists can analyze more samples and increase productivity. The highly inert and exchangeable ion volumes reduce maintenance time to minutes without any venting of the vacuum system. In addition, the HyperQuad technology used in the TSQ Quantum XLS Ultra delivers ultra selective reaction monitoring (U-SRM) for higher detection with notably more selective SRM.
The TSQ Quantum XLS Ultra is designed to offer best-in-class selectivity and precision for a wide range of GC-MS applications, including environmental, food safety, forensics, metabolomics and pharmaceutical. The new DuraBrite IRIS technology offers greater sensitivity, extended maintenance cycles and high routine matrix robustness so scientists can analyze more samples and increase productivity. The highly inert and exchangeable ion volumes reduce maintenance time to minutes without any venting of the vacuum system. In addition, the HyperQuad technology used in the TSQ Quantum XLS Ultra delivers ultra selective reaction monitoring (U-SRM) for higher detection with notably more selective SRM.
Thermo Fisher Scientific Recognized by Computerworld as a 2011 Honors Laureate for Visionary Application of Information Technology
Informatics Solutions Nominated in Health Category
PHILADELPHIA (June 7, 2011) – Thermo Fisher Scientific Inc., the world leader in serving science, today announced that IDG’s Computerworld Honors Program has selected it as a 2011 Laureate. The annual award program honors organizations that create and use information technology to promote and advance public welfare, contribute to the greater good of society and change the world for the better. The 2011 Laureates Chairmen’s Committee Advisors, comprised of the senior leadership of the world’s foremost information technology companies and Computerworld editorial staff, awarded Thermo Fisher for its work with The HUNT Research Centre, part of the Faculty of Medicine at the Norwegian University of Science and Technology, helping it implement a next-generation laboratory information management system (LIMS) to automate their processes from the clinic to the laboratory.
The HUNT Research Center is an integrated family and personal database of approximately 100,000 people in Norway – one of the largest population-based health studies ever performed. Initiated 25 years ago to support epidemiological, clinical and preventative medicine research, HUNT has run three studies that offer valuable insight into disease status and progression, particularly in relation to quality of life measures including environment, education and occupation. HUNT specifically required a comprehensive LIMS to facilitate their ability to gather, store, manage, track and retrieve data securely and yield real-time dependable analysis and reports. Key areas of research include studies on cardiovascular disease, diabetes and lung disorders, as well as thyroid, muscle skeletal and mental diseases and diseases distinctly occurring in men or women.
PHILADELPHIA (June 7, 2011) – Thermo Fisher Scientific Inc., the world leader in serving science, today announced that IDG’s Computerworld Honors Program has selected it as a 2011 Laureate. The annual award program honors organizations that create and use information technology to promote and advance public welfare, contribute to the greater good of society and change the world for the better. The 2011 Laureates Chairmen’s Committee Advisors, comprised of the senior leadership of the world’s foremost information technology companies and Computerworld editorial staff, awarded Thermo Fisher for its work with The HUNT Research Centre, part of the Faculty of Medicine at the Norwegian University of Science and Technology, helping it implement a next-generation laboratory information management system (LIMS) to automate their processes from the clinic to the laboratory.
The HUNT Research Center is an integrated family and personal database of approximately 100,000 people in Norway – one of the largest population-based health studies ever performed. Initiated 25 years ago to support epidemiological, clinical and preventative medicine research, HUNT has run three studies that offer valuable insight into disease status and progression, particularly in relation to quality of life measures including environment, education and occupation. HUNT specifically required a comprehensive LIMS to facilitate their ability to gather, store, manage, track and retrieve data securely and yield real-time dependable analysis and reports. Key areas of research include studies on cardiovascular disease, diabetes and lung disorders, as well as thyroid, muscle skeletal and mental diseases and diseases distinctly occurring in men or women.
Novozymes Biopharma to unveil new research into the production of proteins with extended circulatory half-life at Next Generation Protein Therapeutics Summit
New presentation coincides with launch of AlbufuseFlex albumin fusion technology, designed to overcome challenges associated with the therapeutic use of peptides and proteins.
NOTTINGHAM, UK – June 7, 2011 – Novozymes Biopharma, part of Novozymes A/S, the world leader in bioinnovation, today announced that it will present the company’s latest research into the development of proteins with extended circulatory half-life at the Next Generation Protein Therapeutics Summit 2011, taking place June 20-22, San Francisco, CA. The presentation which offers new insight into the production of albumin fusions, will describe Novozymes’ new AlbufuseFlex technology. The technology is expected to have applications in drug delivery where it may be used to tailor drug half life, thereby enhancing effectiveness while improving patient quality of life. For more information, please visit www.biopharma.novozymes.com.
Dave Mead, business development director at Novozymes Biopharma, comments:
“We are pleased to present our latest advances in albumin fusion technology at The Next Generation Protein Therapeutics Summit. These innovations pave the way for flexibility and efficiency to support manufacturers in developing novel drugs. The company’s new AlbufuseFlex technology illustrates an exciting new era as it can offer the potential to tailor half-life according to specific medical needs.”
NOTTINGHAM, UK – June 7, 2011 – Novozymes Biopharma, part of Novozymes A/S, the world leader in bioinnovation, today announced that it will present the company’s latest research into the development of proteins with extended circulatory half-life at the Next Generation Protein Therapeutics Summit 2011, taking place June 20-22, San Francisco, CA. The presentation which offers new insight into the production of albumin fusions, will describe Novozymes’ new AlbufuseFlex technology. The technology is expected to have applications in drug delivery where it may be used to tailor drug half life, thereby enhancing effectiveness while improving patient quality of life. For more information, please visit www.biopharma.novozymes.com.
Dave Mead, business development director at Novozymes Biopharma, comments:
“We are pleased to present our latest advances in albumin fusion technology at The Next Generation Protein Therapeutics Summit. These innovations pave the way for flexibility and efficiency to support manufacturers in developing novel drugs. The company’s new AlbufuseFlex technology illustrates an exciting new era as it can offer the potential to tailor half-life according to specific medical needs.”
In Shifting Regulatory Climate Greenphire Unveils Latest Clinical Payment Solutions at DIA 2011
Pennsylvania, (07 June 2011) Greenphire, the industry leading provider of clinical payment and communication technology solutions, will showcase its ground breaking clinical payment solutions including ClinCard, an automated payment and communications system and its new ClinicalGPS technology at the annual DIA 2011 symposium in Chicago, Illinois, June 19th to 23rd. To find out more, visit the company at booth #231 at DIA 2011.
Despite the fact that a significant proportion of the adult American population does not possess a bank account, clinical trial sponsors have relied upon costly and time consuming paper checks for subject payment.
Greenphire offers a cost effective, easy-to-use alternative to these traditional paper-based payment methods, promoting recruitment and aiding subject retention both through efficient delivery of funds and the associated execution of study specific subject messaging programs.
Despite the fact that a significant proportion of the adult American population does not possess a bank account, clinical trial sponsors have relied upon costly and time consuming paper checks for subject payment.
Greenphire offers a cost effective, easy-to-use alternative to these traditional paper-based payment methods, promoting recruitment and aiding subject retention both through efficient delivery of funds and the associated execution of study specific subject messaging programs.
Tuesday 7 June 2011
ALMSCO International Highlights Its BenchTOF-dx for Improved Sensitivity at ASMS 2011
Llantrisant, UK (June 6, 2011): ALMSCO International, a division of Markes International Ltd., today announces that it is showcasing its state-of-the-art bench-top time of flight (TOF) mass spectrometer, BenchTOF-dx at ASMS 2011. The instrument is specially designed to generate truly classical electron impact ionization (EI) spectra for gas chromatography (GC) and comprehensive GC/GC applications. It enables users to screen samples at trace levels, offering optimal sensitivity without comprising speed of analyses and selectivity. ALMSCO also highlights its recently launched TargetView software designed to automate and improve detection and measurement of multiple target chemicals in complex GC/MS data sets. When combined with Markes International’s market-leading systems for thermal desorption (TD), it provides a total solution for analysing ultra-trace level components in complex samples. These innovations are being exhibited on ALMSCO’s booth #42 at ASMS 2011, Denver, Colorado, June 5 - June 9, 2011.
Laboratories screening samples at trace levels require a method that offers a blend of sensitivity to enable analysts to monitor the entire sample and enough selectivity to enhance confidence in the results. The BenchTOF-dx features high definition mass spectrometry (MS) technology and combines speed and resolution with uncompromised spectral quality even at trace concentrations. While high resolution accurate mass (HRAM) mass spectrometry is ideal for demanding applications such as proteomics, high definition MS is an alternative and cost-effective compound screening technique that is suited to applications such as forensics, food safety testing and environmental analyses. The novel method enables analysts to screen for both known and unknown compounds at much lower levels with a high degree of definition and clarity. Trace compounds can be clearly identified, quantified and differentiated from one another, while also retaining the required attributes of speed and selectivity.
Laboratories screening samples at trace levels require a method that offers a blend of sensitivity to enable analysts to monitor the entire sample and enough selectivity to enhance confidence in the results. The BenchTOF-dx features high definition mass spectrometry (MS) technology and combines speed and resolution with uncompromised spectral quality even at trace concentrations. While high resolution accurate mass (HRAM) mass spectrometry is ideal for demanding applications such as proteomics, high definition MS is an alternative and cost-effective compound screening technique that is suited to applications such as forensics, food safety testing and environmental analyses. The novel method enables analysts to screen for both known and unknown compounds at much lower levels with a high degree of definition and clarity. Trace compounds can be clearly identified, quantified and differentiated from one another, while also retaining the required attributes of speed and selectivity.
Thermo Fisher Scientific Introduces New Capabilities for Comprehensive Qualitative and Quantitative Proteomics at ASMS 2011
Integrated capabilities offer deeper, broader understanding of proteomes and biological pathways
DENVER (June 6, 2011) - Thermo Fisher Scientific Inc., the world leader in serving science, today introduced new capabilities for laboratories performing a wide range of qualitative and quantitative proteomics workflows. These capabilities integrate seamlessly with the full portfolio of industry leading solutions offered by Thermo Fisher Scientific, providing laboratories with end-to-end workflows that make a deeper and broader understanding of proteomes and biological pathways possible. The new products can be seen in the Thermo Scientific hospitality suite at the Hyatt Regency in Centennial Ballroom D, during the 59th Annual ASMS Conference on Mass Spectrometry and Allied Topics, from June 5–9 in Denver.
“True realization of comprehensive proteomics is an enormous challenge.”
said Andreas Huhmer, proteomics marketing director for life sciences mass spectrometry at Thermo Fisher Scientific. “Overcoming this challenge requires innovative tools that make proteomics analyses more comprehensive in every way. New capabilities, such as our exclusive sample preparation chemistry that targets all kinases in a proteome, will significantly increase the number of proteins scientists can find. Others such as SimGlycan software, offer much more precise characterization of post translational modifications."
DENVER (June 6, 2011) - Thermo Fisher Scientific Inc., the world leader in serving science, today introduced new capabilities for laboratories performing a wide range of qualitative and quantitative proteomics workflows. These capabilities integrate seamlessly with the full portfolio of industry leading solutions offered by Thermo Fisher Scientific, providing laboratories with end-to-end workflows that make a deeper and broader understanding of proteomes and biological pathways possible. The new products can be seen in the Thermo Scientific hospitality suite at the Hyatt Regency in Centennial Ballroom D, during the 59th Annual ASMS Conference on Mass Spectrometry and Allied Topics, from June 5–9 in Denver.
“True realization of comprehensive proteomics is an enormous challenge.”
said Andreas Huhmer, proteomics marketing director for life sciences mass spectrometry at Thermo Fisher Scientific. “Overcoming this challenge requires innovative tools that make proteomics analyses more comprehensive in every way. New capabilities, such as our exclusive sample preparation chemistry that targets all kinases in a proteome, will significantly increase the number of proteins scientists can find. Others such as SimGlycan software, offer much more precise characterization of post translational modifications."
Monday 6 June 2011
Thermo Fisher Scientific Debuts Fastest, More Sensitive Ion Trap Mass Spectrometer at ASMS 2011
Enhanced quantitative and structural characterization capabilities offer exceptional ion trap performance and versatility
DENVER (June, 03, 2011) - Thermo Fisher Scientific Inc., the world leader in serving science, today announced fundamentally redefined ion trap mass spectrometer capabilities with the introduction of its new dual-pressure linear ion trap system, the Thermo Scientific Velos Pro. With improved quantitative performance, faster scanning, Trap-Higher Energy Collision Dissociation (HCD) and enhanced robustness, the Velos Pro mass spectrometer expands the applicability of ion trap workflows.
To extend its capabilities to include ultra-high resolution and accurate mass, the Velos Pro ion trap is also available in combination with industry-leading Thermo Scientific Orbitrap technology as the Orbitrap Velos Pro and Orbitrap Elite hybrid mass spectrometers. The new mass spectrometers can be seen at Thermo Scientific hospitality suite at the Hyatt Regency in Centennial Ballroom D during the 59th Annual ASMS Conference on Mass Spectrometry and Allied Topics, from June 5–9 in Denver.
DENVER (June, 03, 2011) - Thermo Fisher Scientific Inc., the world leader in serving science, today announced fundamentally redefined ion trap mass spectrometer capabilities with the introduction of its new dual-pressure linear ion trap system, the Thermo Scientific Velos Pro. With improved quantitative performance, faster scanning, Trap-Higher Energy Collision Dissociation (HCD) and enhanced robustness, the Velos Pro mass spectrometer expands the applicability of ion trap workflows.
To extend its capabilities to include ultra-high resolution and accurate mass, the Velos Pro ion trap is also available in combination with industry-leading Thermo Scientific Orbitrap technology as the Orbitrap Velos Pro and Orbitrap Elite hybrid mass spectrometers. The new mass spectrometers can be seen at Thermo Scientific hospitality suite at the Hyatt Regency in Centennial Ballroom D during the 59th Annual ASMS Conference on Mass Spectrometry and Allied Topics, from June 5–9 in Denver.
Friday 3 June 2011
SAGE-N RESEARCH SIGNS AN EXCLUSIVE AGREEMENT WITH THE U.S. ARMY EDGEWOOD CHEMICAL BIOLOGICAL CENTER TO LICENSE TECHNOLOGY FOR MICROBIAL IDENTIFICATION
MILPITAS, 2 June 2011 — Sage-N Research, Inc., the world leader in computational proteomics, today announced that it entered into an exclusive license agreement with the U.S. Army Edgewood Chemical Biological Center (ECBC) to commercialize a revolutionary new platform for rapid and sensitive detection and identification of pathogenic microorganisms in fluid media.
This license allows the integration of ECBC’s Agents of Biological Organs Identification (ABOID) system into the company’s existing SORCERER proteomics platform, enabling rapid and cost-effective detection and identification of microorganisms. Currently, the ABOID system can identify 4500 different bacteria, viruses and fungi.
“This cutting edge technology enables identification of microorganisms down to strain level in minutes, rather than hours,” said ECBC Senior Scientist Charles Wick, Ph.D. “This proves very successful for infectious disease identification and a range of other potential applications in military, medical, pharmaceutical, food and public safety areas.”
The new platform will utilize the Computational Power of Sage-N Research’s SORCERER and Mass Spectrometry based Proteomics to identify bacteria, viruses, fungi and other cellular material without the need for growing cultures, or any prior knowledge about them.
In addition, Ali Pervez, Vice President of Sales and Marketing at Sage-N Research comments: “Proteomics is a rapidly emerging field, and Proteomics will play a key role in Life Science and Medical Research over the next five years. We are excited to use our core expertise to bring the power of this cutting edge technology and our SORCERER platform to a wider audience including Infectious diseases, clinical, environmental and food testing markets.”
SORCERER is a trademark of Sage-N Research, Inc.
About Sage-N Research, Inc.
Sage-N Research, Inc. is the world leader in supplying Integrated Data Appliances (IDAs) for proteomics research. The industry-leading SORCERER IDAs are plug-and-play productivity systems used by leading life science researchers worldwide to rapidly and accurately identify proteins and protein modifications in biological samples using mass spectrometry data.
Founded in 2002, the company is a privately held corporation headquartered in San Jose, California in the heart of Silicon Valley. Through strategic collaborations with leading scientists and companies, Sage-N Research advances the state of the art in ease-of-use, applications, and technology to enable world-changing discoveries in biology and medicine. For more information, please visit www.SageNResearch.com
About ECBC
ECBC is the U.S.Army’s principal research and development center for chemical and biological defense technology, engineering and field operations. ECBC has achieved major technological advances for the Warfighter and for our national defense, with a long and distinguished history of providing the Armed Forces with quality systems and outstanding customer service. ECBC is a US Army Research, Development and Engineering Command laboratory located at the Edgewood Area of Aberdeen Proving Ground, Maryland. For more information about the Edgewood Chemical Biological Center, please visit our Web site at http://www.ecbc.army.mil or call (410) 436-7118.
This license allows the integration of ECBC’s Agents of Biological Organs Identification (ABOID) system into the company’s existing SORCERER proteomics platform, enabling rapid and cost-effective detection and identification of microorganisms. Currently, the ABOID system can identify 4500 different bacteria, viruses and fungi.
“This cutting edge technology enables identification of microorganisms down to strain level in minutes, rather than hours,” said ECBC Senior Scientist Charles Wick, Ph.D. “This proves very successful for infectious disease identification and a range of other potential applications in military, medical, pharmaceutical, food and public safety areas.”
The new platform will utilize the Computational Power of Sage-N Research’s SORCERER and Mass Spectrometry based Proteomics to identify bacteria, viruses, fungi and other cellular material without the need for growing cultures, or any prior knowledge about them.
In addition, Ali Pervez, Vice President of Sales and Marketing at Sage-N Research comments: “Proteomics is a rapidly emerging field, and Proteomics will play a key role in Life Science and Medical Research over the next five years. We are excited to use our core expertise to bring the power of this cutting edge technology and our SORCERER platform to a wider audience including Infectious diseases, clinical, environmental and food testing markets.”
SORCERER is a trademark of Sage-N Research, Inc.
About Sage-N Research, Inc.
Sage-N Research, Inc. is the world leader in supplying Integrated Data Appliances (IDAs) for proteomics research. The industry-leading SORCERER IDAs are plug-and-play productivity systems used by leading life science researchers worldwide to rapidly and accurately identify proteins and protein modifications in biological samples using mass spectrometry data.
Founded in 2002, the company is a privately held corporation headquartered in San Jose, California in the heart of Silicon Valley. Through strategic collaborations with leading scientists and companies, Sage-N Research advances the state of the art in ease-of-use, applications, and technology to enable world-changing discoveries in biology and medicine. For more information, please visit www.SageNResearch.com
About ECBC
ECBC is the U.S.Army’s principal research and development center for chemical and biological defense technology, engineering and field operations. ECBC has achieved major technological advances for the Warfighter and for our national defense, with a long and distinguished history of providing the Armed Forces with quality systems and outstanding customer service. ECBC is a US Army Research, Development and Engineering Command laboratory located at the Edgewood Area of Aberdeen Proving Ground, Maryland. For more information about the Edgewood Chemical Biological Center, please visit our Web site at http://www.ecbc.army.mil or call (410) 436-7118.
Thermo Fisher Scientific Introduces New High-Field Orbitrap Mass Spectrometer at ASMS 2011
Novel high-field Orbitrap technology provides exceptional resolving power of >240,000 creating new possibilities in research and discovery
DENVER (June 02 2011) - Thermo Fisher Scientific Inc., the world leader in serving science, today introduced a new milestone in Orbitrap technology, the Thermo Scientific Orbitrap Elite. The Orbitrap Elite hybrid mass spectrometer integrates Thermo Scientific’s faster, more sensitive ion trap - the Thermo Scientific Velos Pro - with the company’s new high-field Orbitrap and advanced signal processing technologies. The system offers outstanding resolving power of 240,000, previously available only on Fourier transform ion cyclotron resonance (FTICR) mass spectrometers, as well as a range of fragmentation techniques, helping customers explore and address the most complex challenges in proteomics, metabolomics, lipidomics and metabolism applications. The new mass spectrometer can be seen in the Thermo Scientific hospitality suite at the Hyatt Regency in Centennial Ballroom D during the 59th Annual ASMS Conference on Mass Spectrometry and Allied Topics, from June 5–9 in Denver.
“Thermo Scientific Orbitrap technology is the recognized standard for accurate mass and high-resolution measurement,” said Thomas Moehring, product manager, Thermo Fisher Scientific. “With the introduction of the high-field Orbitrap and advanced signal processing technology, we created a new standard in ultrahigh resolution and accurate mass for laboratories performing comprehensive proteomics and metabolism studies.”
DENVER (June 02 2011) - Thermo Fisher Scientific Inc., the world leader in serving science, today introduced a new milestone in Orbitrap technology, the Thermo Scientific Orbitrap Elite. The Orbitrap Elite hybrid mass spectrometer integrates Thermo Scientific’s faster, more sensitive ion trap - the Thermo Scientific Velos Pro - with the company’s new high-field Orbitrap and advanced signal processing technologies. The system offers outstanding resolving power of 240,000, previously available only on Fourier transform ion cyclotron resonance (FTICR) mass spectrometers, as well as a range of fragmentation techniques, helping customers explore and address the most complex challenges in proteomics, metabolomics, lipidomics and metabolism applications. The new mass spectrometer can be seen in the Thermo Scientific hospitality suite at the Hyatt Regency in Centennial Ballroom D during the 59th Annual ASMS Conference on Mass Spectrometry and Allied Topics, from June 5–9 in Denver.
“Thermo Scientific Orbitrap technology is the recognized standard for accurate mass and high-resolution measurement,” said Thomas Moehring, product manager, Thermo Fisher Scientific. “With the introduction of the high-field Orbitrap and advanced signal processing technology, we created a new standard in ultrahigh resolution and accurate mass for laboratories performing comprehensive proteomics and metabolism studies.”
Thursday 2 June 2011
Thermo Fisher Scientific Transforms and Simplifies POPs Analysis with Pesticide Analyzer Reference Package
New Package Contains More than 700 Pesticides, PCBs and Dioxins
AUSTIN, Texas (June 2, 2011) – Thermo Fisher Scientific Inc., the world leader in serving science, today announced the second version of the Pesticide Analyzer Method Reference, a unique reference guide that simplifies the analysis of an expanded number of pesticides in environmental and food samples. The new guide transforms the way pesticides and persistent organic pollutants (POPs), such as PCBs, PCDDs and PCDFs are analyzed. The newly revised, all-inclusive solution provides step-by-step information on using the QuEChERS extraction method, including all required consumables. In addition, the Pesticide Analyzer Reference assists users in method development for analyses of pesticides and POPs using the Thermo Scientific TSQ Quantum XLS triple quadrupole GC-MS/MS.
The TSQ Quantum XLS continues to demonstrate that it provides a leading technology for high-throughput, multi-residue screening of a large number of pesticides in a single analytical run, with the highest sensitivity and matrix selectivity. The Pesticide Method Reference can save weeks of method set-up time typically required to optimize analysis conditions for a large number of compounds. All information is provided on compact disc or can be directly uploaded to an instrument. A search tool for compounds, based on scientific, common and trade names, is also included.
AUSTIN, Texas (June 2, 2011) – Thermo Fisher Scientific Inc., the world leader in serving science, today announced the second version of the Pesticide Analyzer Method Reference, a unique reference guide that simplifies the analysis of an expanded number of pesticides in environmental and food samples. The new guide transforms the way pesticides and persistent organic pollutants (POPs), such as PCBs, PCDDs and PCDFs are analyzed. The newly revised, all-inclusive solution provides step-by-step information on using the QuEChERS extraction method, including all required consumables. In addition, the Pesticide Analyzer Reference assists users in method development for analyses of pesticides and POPs using the Thermo Scientific TSQ Quantum XLS triple quadrupole GC-MS/MS.
The TSQ Quantum XLS continues to demonstrate that it provides a leading technology for high-throughput, multi-residue screening of a large number of pesticides in a single analytical run, with the highest sensitivity and matrix selectivity. The Pesticide Method Reference can save weeks of method set-up time typically required to optimize analysis conditions for a large number of compounds. All information is provided on compact disc or can be directly uploaded to an instrument. A search tool for compounds, based on scientific, common and trade names, is also included.
Thermo Fisher Scientific Debuts High-Performance Benchtop Quadrupole-Orbitrap Mass Spectrometer at ASMS 2011
Single-run “Quanfirmation” enables identification, quantitation and confirmation of trace-level components in complex mixtures, without compromise
DENVER (June 01, 2011) - Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Thermo Scientific Q Exactive high-performance benchtop quadrupole-Orbitrap LC-MS/MS. It is the first commercially available instrument to bring together quadrupole precursor selection and high-resolution accurate mass (HR/AM) Orbitrap mass analysis to deliver high confidence quantitative and qualitative (quan/qual) workflows.
With innovative HR/AM Quanfirmation capability, the Q Exactive mass spectrometer makes it possible to identify, quantify and confirm more trace-level metabolites, contaminants, peptides and proteins in complex mixtures-in one analytical run. Unlike other technologies, high confidence results are obtained without sacrificing MS/MS sensitivity, mass resolution or quantitative reproducibility. The Q Exactive system will be on display at Thermo Scientific Booth 110 or the Thermo Scientific hospitality suite at the Hyatt Regency in Centennial Ballroom D during the 59th ASMS Conference on Mass Spectrometry and Allied Topics, from June 5-9 in Denver.
DENVER (June 01, 2011) - Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Thermo Scientific Q Exactive high-performance benchtop quadrupole-Orbitrap LC-MS/MS. It is the first commercially available instrument to bring together quadrupole precursor selection and high-resolution accurate mass (HR/AM) Orbitrap mass analysis to deliver high confidence quantitative and qualitative (quan/qual) workflows.
With innovative HR/AM Quanfirmation capability, the Q Exactive mass spectrometer makes it possible to identify, quantify and confirm more trace-level metabolites, contaminants, peptides and proteins in complex mixtures-in one analytical run. Unlike other technologies, high confidence results are obtained without sacrificing MS/MS sensitivity, mass resolution or quantitative reproducibility. The Q Exactive system will be on display at Thermo Scientific Booth 110 or the Thermo Scientific hospitality suite at the Hyatt Regency in Centennial Ballroom D during the 59th ASMS Conference on Mass Spectrometry and Allied Topics, from June 5-9 in Denver.
Subscribe to:
Posts (Atom)